Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 22, 2025
Short-term modification of breathprint by Elexacaftor/Tezacaftor/Ivacaftor in a paediatric cohortEmmanuelle Bardin, Nicolas Hunzinger, Elodie Lamy, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 2, 2021
"Il faut continuer à poser des questions" patient reported outcome measures in cystic fibrosis: An anthropological perspectiveRosa Coucke, Audrey Chansard, Véronique Bontemps, et al.FEMS Microbiology Letters|September 1, 2017
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosisWynne D Smith, Emmanuelle Bardin, Loren Cameron, et al.Expert Review of Respiratory Medicine|May 14, 2016
Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approachesHelena Lund-Palau, Andrew R Turnbull, Andrew Bush, et al.Clinical Pharmacokinetics|February 4, 2024
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized TherapyNaïm Bouazza, Saïk Urien, Frantz Foissac, et al.Clinical and Translational Science|May 10, 2025
Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic FibrosisNgoc Hoa Truong, Sihem Benaboud, Naïm Bouazza, et al.Pageof 2